POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify

Sonia Prot-Labarthe1, Thomas Weil2, François Angoulvant3

  • 1Pharmacie, AP-HP Hôpital Robert-Debré, Paris, France.

Plos One
|July 1, 2014
PubMed

Insights

A new tool, POPI, was developed to identify inappropriate prescriptions and drug omissions in children. This screening tool, based on expert consensus, aims to improve rational prescribing in pediatrics and reduce medication errors.

Area of Science:

  • Pediatric Pharmacology
  • Medication Safety
  • Health Informatics

Background:

  • Rational prescribing in children is a global challenge with insufficient research.
  • Medication errors, including inappropriate prescriptions and omissions, are prevalent in pediatric populations.
  • Existing guidelines require a dedicated screening tool for pediatric prescription analysis.

Purpose of the Study:

  • To develop a screening tool for identifying inappropriate prescriptions and drug omissions in pediatric care.
  • To base the tool on established French and international pediatric prescribing guidelines.
  • To enhance the safety and appropriateness of medication use in children.

Main Methods:

  • Disease selection based on social security and hospital statistics.
  • Literature review to identify explicit criteria for the POPI tool.
  • Two-round Delphi consensus technique with 16 expert panelists (pharmacists and pediatricians) using a 9-point Likert scale.

Main Results:

  • Developed 108 explicit criteria (80 for inappropriate prescriptions, 28 for omissions).
  • Criteria categorized by physiological systems (gastroenterology, respiratory, pain, neurology, dermatology, miscellaneous).
  • After two Delphi rounds, 104 criteria (79 inappropriate prescriptions, 25 omissions) were validated by experts.

Conclusions:

  • POPI is the first screening tool specifically designed to detect inappropriate prescriptions and omissions in pediatrics.
  • Further research, including inter-user reliability and prospective effectiveness studies, is required.
  • The tool aims to improve medication safety and rational prescribing practices in pediatric patients.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
401
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392